India Ministries Consider Mylan Takeover Of Agila With Strings Attached
This article was originally published in PharmAsia News
Several India ministries are weighing in on the Mylan Laboratories proposal to buy Agila Specialties, the injectables unit of Strides Arcolabs for $1.6 billion, including making approval unusually conditional.
You may also be interested in...
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.
Market Intel: Why Telehealth, Digital Therapies Will Provide Mental Health Support Beyond COVID-19 Crisis
In this second part of a two-part series focusing on mental health tech, Medtech Insight highlights behavioral digital health companies that have attracted investors’ attention. Part one focused on transcranial magnetic stimulation.